Supreium Technology
Series B in 2024
Supreium Technology is a developer of advanced die-casting computer-aided engineering (CAE) simulation software, specializing in intelligent manufacturing solutions. Founded in 2016 and based in Beijing, China, the company offers a software as a service (SaaS) platform that includes a range of services such as mold design, injection process analysis, and automatic defect detection through image scanning. Supreium also provides process consulting, focusing on areas like gate and runner design as well as thermal balance analysis. Its solutions cater to various industries, including medical treatment, marine water conservancy, communications, and industrial sectors. The company emphasizes intelligent algorithms and high-performance CAE technologies to deliver innovative digital solutions for its clients.
Xvisio Technology
Series B in 2024
Xvisio Technology is a company based in Shanghai, China, with an additional office in Milpitas, California, focused on designing and developing virtual reality (XR) products and core spatial perception technologies. The company specializes in Visual Simultaneous Localization and Mapping (VSLAM) technologies, which enable precise mapping, 3D environment reconstruction, and object recognition for XR applications. Xvisio's product offerings include the SeerSense sensor hub module, which features low latency 6DOF tracking, depth sensing, and AI inference for applications in robotics, autonomous vehicle navigation, and security, as well as the SeerLens AR glasses that incorporate 6DOF tracking. These products cater to various industries, including robotics, drones, logistics, gaming, manufacturing, and automotive, supporting use cases such as remote assistance, education, AR navigation, and more.
Hangxing Transmission
Series A in 2024
Beijing Hangxing Transmission Technology is a development and batch production of various servo systems in the fields of aerospace, aviation and navigation. They have rich experience in industry development and mass production and have more than 40 R&D and design personnel, craftsmen, and skilled personnel.
Bio-Link
Venture Round in 2024
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.
Mingdu Zhiyun
Series C in 2024
Mingdu Intelligent, established in 2017 and headquartered in Hangzhou, China, specializes in providing comprehensive contract manufacturing services for pharmaceutical companies. The company offers full life cycle solutions, encompassing research and development (R&D), production, warehousing, and logistics. Mingdu Intelligent leverages an advanced information management system powered by big data and artificial intelligence to enhance the efficiency of the R&D process and streamline the application, production, and registration of pharmaceutical products.
Edrive Space
Series B in 2024
Edrive Space specializes in the development of aerospace propulsion systems, focusing on electrothermal micro-propulsion technology. This innovative approach addresses the limitations of traditional electric propulsion systems, which often suffer from issues related to weight, power consumption, and thrust. Edrive Space's products are tailored for the rapid deployment and networking of micro-nano satellites, making them ideal for applications such as emergency collision avoidance of space debris and active deorbiting. The company's solutions are designed to meet the demands for low-cost, standardized, and batch-produced propulsion systems, thereby supporting the growth of the aerospace industry, particularly within China.
Unitree Robotics
Series B in 2024
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions tailored for consumer and industrial markets. The company's portfolio features a variety of robots, including Laikago, a four-legged robodog that serves as a research platform for scientists and roboticists. Unitree Robotics aims to advance robotic technology through its diverse range of products, which also includes humanoid robots and advanced perception systems designed for various applications.
Homerun Smart
Series C in 2023
Shenzhen Qianhai Homerun Technology Co., Ltd. specializes in developing smart pet technology aimed at enhancing the lives of pet owners. Founded in 2015 and headquartered in Guangzhou, China, the company creates innovative products such as smart pet feeders, pet fountains, and smart cat toys. Utilizing artificial intelligence, Homerun Technology focuses on designing solutions that cater to the needs of urban pet owners, particularly those who may have busy lifestyles. The company employs a skilled team of researchers from both domestic and international backgrounds to ensure high-quality development of its products. By integrating smart hardware into daily life, Homerun Technology aims to redefine the pet ownership experience and contribute positively to the pet industry.
Zhongke Tuoda
Series A in 2023
Zhongke Tuoda is a company focused on addressing key challenges in China's agriculture through innovative physical technology. It develops fertilizers and pesticides designed to minimize pollution and enhance agricultural practices. The company is dedicated to improving agricultural environmental protection and ensuring the safety of agricultural products. By optimizing the supply-side structure of agricultural products, Zhongke Tuoda aims to reduce reliance on harmful chemical fertilizers and pesticides, contributing to a more sustainable agricultural landscape in China.
Voyager Technology
Series B in 2023
Voyager Technology Inc. is a manufacturer and provider of automotive electronics systems, specializing in advanced driving assistant systems and solutions for autonomous driving. Established in 2013 and headquartered in Shanghai, China, the company focuses on critical components such as environmental perception, intelligent decision-making, and control execution. Voyager Technology is dedicated to offering customers safe and efficient intelligent travel solutions, positioning itself as a key player in the evolving automotive technology sector.
Hainayun is a prominent developer of IoT solutions focused on creating smart communities and smart parks essential for the development of smart cities in China. As a subsidiary of the Haier Group, Hainayun aims to establish itself as the leading IoT digital city eco-platform in the country while setting industry standards for the promotion of a Digital China. The company provides a comprehensive range of services, including digital infrastructure construction, building lifecycle management, and big data operations. By leveraging its expertise in Artificial Internet of Things (AIoT), Hainayun supports enterprises in their efforts to develop and manage digital city ecosystems effectively.
EPiCMEMS
Venture Round in 2022
Kaiyuan Communication Technology (Xiamen) Co., Ltd. is a specialized chip manufacturer based in Haicang District, Xiamen City. The company focuses on providing RF front-end solutions, developing advanced 4G+ and 5G RF filters and chips aimed at enhancing the domestic chip industry. With operational facilities in Zhangjiang, Shanghai, and sales and customer support centers in Shenzhen, Xi'an, and Beijing, Kaiyuan is positioned to serve the mobile device sector and the burgeoning Internet of Things (IoT) market. Its products are designed to deliver high-speed, high-quality connectivity, enabling users to experience faster and more stable connections in their devices.
GAC Aion New Energy Automobile
Series A in 2022
GAC Aion New Energy Automobile is a Chinese manufacturer of electric vehicles, established in 2017 as a sub-brand of Guangzhou Automobile Corporation and officially launched as a marque in 2020. The company focuses on the development of new energy automobiles, aiming to deliver intelligent vehicles that enhance the driving experience for customers. GAC Aion emphasizes innovation and sustainability in its product offerings, contributing to the growing electric vehicle market in China.
Linli New Energy
Series B in 2022
Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China.
MicroPort (Shanghai)
Post in 2022
MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company focuses on the development, promotion, and application of quantum computing technologies. Its offerings include quantum chips, measurement and control systems, and quantum software, which encompasses both content and various algorithms. Additionally, Origin Quantum provides a quantum computing cloud service platform, facilitating broader access to quantum technologies beyond laboratory environments. The company is dedicated to advancing the engineering and industrialization of quantum computing, aiming to accelerate its practical applications across various sectors in China.
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
Tuowei Tianhai
Series A in 2022
TWTH committed to minimizing export costs of logistics in China by establishing the most convenient and efficient Sino-US transport brand. It is dedicated to providing Sino-US ocean freight LCL Door-to-Door service, air freight Door-to-Door service, ocean freight FCL Door-to-Door service, international express service, CNRAM and other international freight services.
Shenzhen MTC Company
Post in 2022
Shenzhen MTC Co., Ltd. is a China-based company established in 2005, headquartered in Shenzhen. It specializes in the design, development, and manufacturing of a diverse range of digital products, including LCD TVs, set-top boxes, LED components, and network communication devices. The company also engages in the production of Internet entertainment products and offers advanced television technologies such as 3D, 4K, and QLED TVs. Additionally, Shenzhen MTC provides residential and commercial lighting solutions, encompassing decorative and functional lightings, as well as outdoor lighting products. Through continuous technological innovation, the company strives to enhance its product offerings and improve its systems.
Unitree Robotics
Series B in 2022
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions tailored for consumer and industrial markets. The company's portfolio features a variety of robots, including Laikago, a four-legged robodog that serves as a research platform for scientists and roboticists. Unitree Robotics aims to advance robotic technology through its diverse range of products, which also includes humanoid robots and advanced perception systems designed for various applications.
Phylion Battery
Venture Round in 2022
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
Regend Therapeutics
Series B in 2022
Regend Therapeutics is a leading company in the field of human organ regenerative medicine, specializing in the development of stem cell therapy products. Its flagship product, REGEND001, is the world's first autologous stem cell preparation for treating respiratory diseases and has received approval from the State Food and Drug Administration. Regend Therapeutics is notable for being the first organization in China to be registered for conducting clinical research on stem cells, with its operations overseen by the National Health and Health Commission. The company is recognized as a key player in research and development by the Ministry of Science and Technology. Regend has achieved ISO9001:2008 quality management system certification, and its stem cell preparation complies with various national and international standards, including China Metrology Accreditation and the China Conformity Assessment Committee. All clinical programs are conducted in accordance with regulatory guidelines and are registered with the National Trial Global Database of the National Institutes of Health. The company's research focuses on solutions for interstitial lung disease, assisted reproduction, stem cell storage, and chronic obstructive pulmonary disease.
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company produces models such as the Nezha U, Nezha N01, and Eureka 02, focusing on integrating innovative technology through research and development. Hozon emphasizes intelligent manufacturing and multi-channel sales services, aiming to deliver high-quality, cost-effective intelligent electric vehicles. By prioritizing advancements in electricity, intelligence, and connectivity, Hozon seeks to enhance the user experience, providing a simple, intuitive, and comfortable mode of transportation. The company also maintains research and development centers in both China and the United States.
Panchip
Private Equity Round in 2022
PanChip, established in 2010 and based in Suzhou, China, specializes in the design and development of short-distance wireless communication RF chips. The company offers a range of products including low-power real-time clock chips, touch screen controller chips, and system solutions tailored for various applications such as wireless mice, audio devices, mobile phone touch screens, keyboards, remote controls, toys, game keypads, and industrial control systems. PanChip is also involved in creating wireless spread spectrum communication platforms, low-power WAN physical layer chips, and high-precision indoor positioning systems, aiming to provide advanced and high-quality domestically produced chips for businesses.
H-CHIP TECH
Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.
Value Simplex
Series B in 2021
Value Simplex is a company that specializes in big data, machine learning, and management services tailored for the financial industry. Established in 2017 and headquartered in Shanghai, China, it develops intelligent investment decision-making tools that offer alternative data for projecting company performance and products. Value Simplex also cultivates external data through a platform that utilizes machine learning, allowing clients to improve the accuracy and efficiency of their investment research. By providing long-term data accumulation and insights from time-series data, the company equips its customers with the necessary resources to enhance their investment decision-making processes.
Leyue Health
Series B in 2021
Leyue Health, operated by Leyo Information Technology (Shanghai) Co., Ltd., is an innovative platform that integrates internet technology with medical health services. The company specializes in developing a commercial insurance direct payment platform that facilitates real-time online settlement of claims, significantly reducing the traditional 30-day claims processing time. By streamlining the reimbursement process, Leyue Health addresses common challenges faced by medical institutions and insurance providers, enhancing the user experience for insurance beneficiaries. In addition to its core settlement services, the company offers a mobile application that enables users to make appointments, manage test results, and process payments seamlessly. Leyue Health's approach fosters a more efficient and user-friendly connection between medical institutions and insurance providers, marking a significant advancement in the integration of healthcare and insurance technology.
Shenzhen Jimuyida Technology Co., Ltd., located in Shenzhen, China, is a prominent provider of 3D digital technology. The company specializes in the development of augmented reality and 3D modeling technologies, offering a range of products and services that include 3D scanners, engineering modeling services, and home improvement design tools. Additionally, Jimuyida provides 3D scene customization services that leverage holographic, augmented reality, and virtual reality technologies. Their innovative software solutions enable users in various sectors, such as retail, design, and real estate, to create detailed and interactive models, enhancing the visualization and presentation of products to customers.
Harmony Cloud
Series C in 2021
Harmony Cloud, officially known as Hangzhou HarmonyCloud Technology Co., Ltd., is a cloud computing startup focused on enhancing IT support for traditional enterprises. The company specializes in a Container as a Service (CaaS) platform that facilitates efficient hybrid cloud management. Utilizing the Kubernetes framework, Harmony Cloud's platform incorporates advanced technologies such as elastic computing, distributed deployment storage, and software-defined networking. It also features mirror-level security scanning and a graphical user interface for cloud operation and maintenance. By offering these innovations, Harmony Cloud aims to streamline resource and application management, accelerate application delivery, and enhance operational efficiency for its customers in the Chinese market.
EQ Consulting
Seed Round in 2021
EQ Consulting is a financial consulting firm that specializes in delivering tailored solutions to large and medium-sized financial institutions globally. The company focuses on a range of services, including business consulting, product development, and project implementation, along with comprehensive system solutions. EQ Consulting excels in providing customized financial product quantitative modeling, front-end trading, risk control, and back-office services to meet the specific needs of its clients. With a client base that includes prominent commercial banks and financial institutions in Hong Kong and Singapore, EQ Consulting is committed to enhancing operational efficiency and risk management for its partners. The firm is also dedicated to innovation and growth, utilizing recent funding to develop new products, advance its technology, and expand its services internationally.
Beijing Sudo Technology
Series A in 2021
Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.
Leads Biolabs
Series C in 2021
Leads Biolabs is a biotechnology company based in China that focuses on developing innovative antibody-based therapeutics for oncology and immunological diseases. Founded in 2014, the company is dedicated to addressing global unmet medical needs by creating biopharmaceutical products that enhance treatment outcomes for patients. Leads Biolabs has established a strong research and development pipeline, featuring over ten projects centered on monoclonal and bispecific antibodies aimed at cancer immunotherapy. Through its commitment to advancing tumor immunotherapy, the company strives to improve the medical treatment and overall conditions of patients facing cancer.
Zhiduoji Microelectronics
Series C in 2021
Zhiduoji Microelectronics focuses on the research and development of programmable logic circuit device technology. Established in 2012, it is headquartered in Xi'an, and has an EDA software research center in Beijing.
Jiepei.com
Series B in 2021
Jiepei.com Inc. is a company based in Hangzhou, China, specializing in the manufacturing of printed circuit boards (PCBs) and operating as an online marketplace for electronic components. The company aims to create a collaborative platform for the electronic information industry, focusing on a variety of sectors including consumer electronics, communications equipment, industrial control, instrumentation, intelligent hardware, and the Internet of Things. Jiepei.com offers comprehensive one-stop services, including PCB customization, surface mount technology (SMT), and component distribution, catering to the diverse needs of manufacturers within these industries.
IPLUSMOBOT
Series B in 2021
IPLUSMOBOT is one of the global leading companies in the autonomous mobile robot field, ranking the first of China industrial logistics natural navigation AMR market occupancy. IPLUSMOBOT was founded in 2016, whose headquarter is in Hangzhou and its subcompany have been established in Shenzhen and Tokyo. It provides logistics automatic, digital and intelligentized products to manufacturing industry, and helps enterprises increase the configuration efficiency of production and circulation resources, and integrated operation efficiency and benefits. So far, IPLUSMOBOT has served over 1000 customers, and the business scenes cover such industries as semiconductor, FPD, electronics, Lithium battery, photovoltaic, automobile, aviation, household electrical appliances, pharmaceutical, energy, food industry and so on.
Yunphant Blockchain
Series B in 2021
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Longcheer
Series B in 2021
Longcheer is a Shanghai-based company that specializes in providing design solutions for mobile telecommunications devices. Founded in 2002, it offers a comprehensive range of services, including hardware and software development, system testing, and exterior design. The company is involved in the research, development, and manufacturing of various terminals, such as smartphones, tablets, AI PCs, XR products, AIoT devices, and automotive electronics. Additionally, Longcheer manufactures, sells, and trades mobile handsets, printed circuits, data products, and related materials. Beyond its core technology services, Longcheer also engages in property investment activities.
TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.
Moore Threads
Seed Round in 2021
Moore Threads, founded in 2020 and located in Beijing, China, specializes in the development of Graphics Processing Unit (GPU) technology tailored for various applications, including visual computing, artificial intelligence, and high-performance computing. The company provides advanced GPU technology and services to corporate clients across multiple sectors, such as gaming and the creative industry. Its offerings include solutions for data centers, edge computing servers, professional workstations, and high-performance personal computers, allowing clients to execute complex computational tasks efficiently.
Cryofocus Biotech
Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.
Sino Vision
Series D in 2020
SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.
Htrip is a tourism company based in Guangzhou, China, that focuses on data analysis for hotels. Founded in 2016, it enhances hotel services and profitability by tracking user habits. Htrip specializes in developing an Internet communication platform for hotels, which includes upgrading interactive television, Wi-Fi, and Internet of Things (IoT) hardware in guest rooms. The company achieves this through self-investment in technology or partnerships with hotels, integrating its solutions with existing property management systems.
UnionTech
Series A in 2020
UnionTech is a Chinese software company established in 2019, headquartered in Beijing, with a mission to foster an innovation ecosystem around Chinese operating systems. The company specializes in the development and provision of basic software, particularly focusing on operating systems and related solutions. It aims to deliver secure, stable, intelligent, and user-friendly operating systems tailored for various industries. UnionTech also develops software compatible with its Unity Operating System, which is based on Linux technology, enhancing users' access to efficient operating system capabilities. To support its operations, the company has established local technical support institutions, research and development centers, and software and hardware adaptation centers in cities such as Wuhan, Shanghai, Guangzhou, and Nanjing.
Eigencomm
Series B in 2020
Eigencomm Ltd. is a Shanghai-based company established in 2017 that specializes in the research, development, and sales of cellular network internet chips. The company focuses on creating turnkey solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. Eigencomm offers standard NB-IoT terminal chips that ensure comprehensive cellular data connectivity and extended standby durations, positioning itself as a key player in the cellular IoT market.
FJ Dynamics
Venture Round in 2020
FJ Dynamics is a global robotics company founded in 2017 and headquartered in China. The company specializes in developing digital and autonomous solutions for various sectors, with a strong focus on agriculture and construction. FJ Dynamics integrates advanced technologies such as big data, the Internet of Things, deep learning, unmanned driving, and machine vision to create intelligent logistics robots and innovative agricultural machinery. Their product offerings include intelligent ground robots, terminal unmanned logistics systems, agricultural robots, and high-speed rice transplanters. By enhancing productivity and efficiency in the agricultural industry, FJ Dynamics aims to transform traditional practices through automation and smart technology.
Chasing Innovation
Series A in 2020
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones designed for underwater exploration and observation. With additional offices in Beijing, Kunming, and Chengdu, the company is driven by a team of enthusiasts with expertise from prominent organizations. Its flagship product, the Gladius, is a sophisticated submersible drone capable of diving up to 100 meters and featuring a horizontal range of 500 meters. The Gladius is engineered for versatility in various applications such as diving, fishing, search and rescue missions, and aquaculture monitoring. It offers the ability to capture ultra-high-definition images and videos while submerged for up to three hours, with options for internal storage or live streaming. Chasing Innovation aims to enhance underwater experiences and facilitate effective exploration with its innovative solutions.
LP Pharmaceuticals
Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Wenge Group
Series C in 2020
Beijing Zhongke Wenge Technology Co., Ltd., located in Beijing, China, specializes in big data applications for the media sector. The company focuses on providing technological solutions to facilitate the transformation and enhancement of media communication in China. It is actively engaged in the research and development of new media big data technologies and systems, addressing the needs of media, government, and enterprises. Zhongke Wenge has developed a comprehensive suite of products, including the "Wenhai" new media big data platform, the "Wen Ge" central kitchen, and the "Wen Si" decision-making service. Additionally, it offers key services such as the “cloud trace” communication monitoring system, the “Yunyong” media visualization analysis system, and the “Yayi” text semantic analysis component, which collectively support media organizations in improving communication effectiveness and decision-making capabilities.
Shanghai Horizon Medical Technology
Venture Round in 2020
Shanghai Horizon Medical Technology focuses on medical solutions its business covers the R&D, manufacturing, marketing, and technical support of products at every step of the ART treatment process, including egg and sperm collection, fertilization, embryo culture, cryopreservation, and embryo transfer. It was founded in 2018 and headquartered in Shanghai, China.
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.
Encootech
Series B in 2020
Encootech, established in 2017 and headquartered in Shanghai, China, specializes in developing and providing intelligent Robotic Process Automation (RPA) platforms and solutions. The company, initially founded as Shanghai Yunsheng Information Technology Co., Ltd., was the first in China to focus on RPA software robot platform development. Encootech's core team, comprising technical experts from Microsoft's cloud computing department, independently created Digi4th, the first intelligent RPA robot platform in China. The company offers RPA products and solutions to various industries, including the internet, finance, energy, telecommunications, and manufacturing, aiming to boost operational efficiency and accelerate digital transformation.
GenFleet Therapeutics
Series B in 2020
GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.
Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.
Maijing Gene
Series B in 2020
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
RemeGen
Private Equity Round in 2019
RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, focused on addressing unmet medical needs for patients with life-threatening conditions. The company specializes in the research, development, manufacturing, and commercialization of innovative biologics, particularly monoclonal antibodies and antibody-drug conjugates. RemeGen's leading products include Telitacicept, aimed at treating systemic lupus erythematosus, and Disitamab Vedotin, designed for various cancers. The company’s therapeutic offerings target significant health issues, including autoimmune diseases, oncology, and ophthalmology. With operations in both China and the United States, RemeGen primarily generates its revenue from the Chinese market.
Htrip is a tourism company based in Guangzhou, China, that focuses on data analysis for hotels. Founded in 2016, it enhances hotel services and profitability by tracking user habits. Htrip specializes in developing an Internet communication platform for hotels, which includes upgrading interactive television, Wi-Fi, and Internet of Things (IoT) hardware in guest rooms. The company achieves this through self-investment in technology or partnerships with hotels, integrating its solutions with existing property management systems.
Eigencomm
Venture Round in 2019
Eigencomm Ltd. is a Shanghai-based company established in 2017 that specializes in the research, development, and sales of cellular network internet chips. The company focuses on creating turnkey solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. Eigencomm offers standard NB-IoT terminal chips that ensure comprehensive cellular data connectivity and extended standby durations, positioning itself as a key player in the cellular IoT market.
Akeso Biopharma
Series D in 2019
Akeso Biopharma, Inc. is a contract research organization based in Zhongshan, China, specializing in the discovery and development of antibody and protein drugs. Established in 2012, the company offers a range of integrated services to both domestic and international pharmaceutical firms, including protein expression and purification, antibody generation, assay development, humanization, and affinity maturation. Akeso has developed a comprehensive biopharmaceutical research and development platform, focusing on therapeutic areas such as cancer, autoimmune diseases, inflammation, and cardiovascular diseases. With a robust pipeline of over 30 drug candidates, 17 of which are in clinical stages, Akeso is recognized for its innovative approaches, including the development of first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical enterprises to advance the joint development of new drugs, positioning itself as a leader in the biopharmaceutical industry.
Golden Technology
Series B in 2019
Golden Technology is a big data service company based in China that specializes in providing electronic invoicing solutions through blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform designed to serve various sectors, including grocery retailers, parking lots, and restaurants. Its platform offers a range of services such as electronic invoicing, reimbursement, record-keeping, and transaction inspection and management. By leveraging blockchain, Golden Technology aims to provide convenient and cost-effective alternatives to traditional paper-based receipts, enhancing the efficiency and transparency of financial transactions.
Fapiaoer is a Chinese electronic invoicing service provider under Tencent-backed Chinese project incubator and group-buying platform GaoPeng. Based on a variety of business success stories, with a strong operating, technical, product team, Gao Peng internal restructuring team to provide electronic invoicing services in an effort to create the most convenient and most reasonable electronic invoice preparation, preservation, and reimbursement experience for users. , Tencent and U.S. GROUPON Each group invested 50 million U.S. dollars to develop a group purchasing business company to become: Wechat commercialization project incubation platform, Tencent eco-layout early investment platform, Group purchasing model integration optimization of new e-commerce platform and other three business lines go hand in hand with diversified technology The company, currently Tencent, is the single largest shareholder of Gao Peng.
Hrain Biotechnology
Series B in 2019
Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on delivering precise treatments for cancer patients. The company employs Chimeric Antigen Receptor T-cell (CAR-T) technology to enhance the effectiveness of cancer therapies. By establishing clinical trial platforms in various locations, including Beijing, Jiangsu, Chongqing, and Henan, Hrain Biotechnology facilitates the development and implementation of innovative medical treatments in clinical settings. Through its research and technology, the company aims to improve patient outcomes by enabling hospitals and clinics to offer advanced therapeutic solutions tailored to individual needs.
Mino Space
Series A in 2019
Mino Space is a private commercial satellite company focused on the development and application of micro-nano satellite systems. Established in 2017 and based in Beijing, the company specializes in research and development, manufacturing services, and the integration of satellite technologies. Mino Space independently designs and develops micro-nano satellite platforms and core components, including electronic communication and optical payloads. The company has significant experience in satellite communication system integration and also develops terrestrial communication terminals. Mino Space offers integrated information system solutions that leverage satellite resources for various sectors, including defense and industry. Its capabilities encompass the coordination of satellite development and overall project management, contributing to advancements in space exploration and communication technologies.
ArchForce Technology
Series B in 2019
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, a trading platform, a risk control system, and a trading highway, catering to the needs of securities firms, funds, banks, and insurance companies. The company's offerings support transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing, contributing to the advancement of China's financial infrastructure.
Shanghai Anlogic Infotech Co., Ltd., established in 2011 and headquartered in Zhangjiang Hi-Tech Park, Pudong New Area, specializes in the research, development, design, and sale of cost-effective programmable logic devices, including FPGAs and programmable system-on-chips. The company also offers custom embedded eFPGA IPs and dedicated electronic design automation software, as well as innovative system solutions tailored to meet various industry needs. Anlogic is committed to advancing technology in the field of programmable logic and providing efficient design tools to facilitate the development of complex electronic systems.
Innoviz Technologies
Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.
Innoviz Technologies
Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.
KK Group operates an online-to-offline marketplace for imported products in China. The company specializes in sourcing a diverse range of items, including snacks, personal care products, makeup, home furnishings, stationery, and other goods from well-known international brands. By utilizing both physical stores and online e-commerce platforms, KK Group offers consumers direct access to premium imported products, allowing shoppers to conveniently purchase items through their mobile devices. This innovative approach bridges the gap between online shopping and physical retail, enhancing the consumer experience in accessing high-quality goods from around the world.
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.
TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.
Vhall is an online activity marketing and commercial platform based in China, specializing in virtual meetings and live broadcasting services. Affiliated with Beijing Vhall Time Science and Technology Co., Ltd., the company aims to provide a high-quality online marketing solution for Chinese enterprises. Vhall's platform facilitates interactive experiences in a 3D virtual reality environment, allowing participants to engage in live seminars, explore exhibition booths, view product demonstrations, and communicate with organizers and exhibitors through a simple web link. By offering comprehensive services for online training and remote meetings, Vhall enhances work efficiency and enables seamless communication without the need for in-person interactions.
Databaker Technology
Series A in 2018
Databaker Technology, founded in 2016 and based in Beijing, China, specializes in intelligent voice interaction and AI data services. The company offers a comprehensive suite of services, including voice synthesis, speech recognition, text-to-speech solutions, and image data annotation and collection. By leveraging an open AI and SaaS platform, Databaker provides enterprises with tailored voice interaction products that enhance their applications. The company's focus on a diverse range of data types, including voice, image, and text, enables it to meet the evolving needs of its clients in the AI-driven technology landscape.
Yunphant Blockchain
Series A in 2018
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Akeso Biopharma
Series C in 2018
Akeso Biopharma, Inc. is a contract research organization based in Zhongshan, China, specializing in the discovery and development of antibody and protein drugs. Established in 2012, the company offers a range of integrated services to both domestic and international pharmaceutical firms, including protein expression and purification, antibody generation, assay development, humanization, and affinity maturation. Akeso has developed a comprehensive biopharmaceutical research and development platform, focusing on therapeutic areas such as cancer, autoimmune diseases, inflammation, and cardiovascular diseases. With a robust pipeline of over 30 drug candidates, 17 of which are in clinical stages, Akeso is recognized for its innovative approaches, including the development of first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical enterprises to advance the joint development of new drugs, positioning itself as a leader in the biopharmaceutical industry.
XTX Technology
Series B in 2018
XTX Technology Limited is a semiconductor company based in Shenzhen, China, specializing in high-reliability memory solutions. The company manufactures a variety of flash memory products, including NAND MCP, NOR MCP, SD NAND, and SPI flash, which cater to diverse embedded applications such as mobile devices, automotive equipment, security systems, and home appliances. Additionally, XTX Technology offers System in Package (SIP) assembly services aimed at optimizing customer bill of materials costs and enhancing production efficiency while ensuring software intellectual property security. The company's innovations in semiconductor technology also accommodate various temperature tolerances, supporting a range of applications in consumer electronics, industrial sectors, and medical care.
Teligene Ltd., established in 2011 and headquartered in Jiangsu, China, is a pharmaceutical research and development company specializing in the creation of small-molecule drugs for oncology. The company's senior management team, experienced in advanced drug development technologies, focuses on researching and developing innovative, targeted anti-tumor drugs with independent intellectual property rights.
Shenzhen Raybow Optoelectronics
Series A in 2018
Shenzhen Raybow Optoelectronics Co., Ltd., established in Shenzhen, China, specializes in the design and manufacture of high-power semiconductor laser chips. Founded by the Research Institute of Tsinghua University in Shenzhen and industry experts, the company operates a fully functional semiconductor laser chip fabrication line and a packaging and testing facility. Raybow offers some of the market's most powerful and reliable laser diodes, along with advanced testing equipment and services, including design consulting, characterization, and failure mode analysis.
TargetRx
Seed Round in 2018
Shenzhen TargetRx, Inc. is a high-tech pharmaceutical research and development company based in Shenzhen, China, founded in 2014. The company specializes in the research and development of third-generation small molecule targeted anti-tumor drugs aimed at addressing the challenges of drug resistance in cancer treatment. Led by Dr. Yihan Wang, an internationally recognized medical expert with extensive experience in the field, TargetRx focuses on designing, screening, evaluating, and optimizing novel pharmaceuticals for cancer patients. The company has developed a series of innovative anti-cancer solutions that possess independent intellectual property rights, with the goal of transforming cancer from a leading cause of death into a manageable chronic condition. TargetRx's commitment to advancing medical research in oncology is underscored by its dedication to improving treatment efficacy for patients facing the complexities of cancer.
HaploX Biotechnology Co., LTD. is a Shenzhen-based company established in 2014 that focuses on developing genomic solutions for personalized medicine, particularly in cancer patient management. The company specializes in integrating advanced technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data to enhance cancer diagnostics. HaploX's innovative genomics technology enables the extraction and amplification of ultra-low concentrations of DNA from liquid samples, facilitating the precision capture of circulating tumor DNA. By leveraging these advanced methodologies, the company aims to improve the detection and management of ultra-micro tumors, ultimately contributing to more effective patient care in oncology.
Chasing Innovation
Seed Round in 2018
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones designed for underwater exploration and observation. With additional offices in Beijing, Kunming, and Chengdu, the company is driven by a team of enthusiasts with expertise from prominent organizations. Its flagship product, the Gladius, is a sophisticated submersible drone capable of diving up to 100 meters and featuring a horizontal range of 500 meters. The Gladius is engineered for versatility in various applications such as diving, fishing, search and rescue missions, and aquaculture monitoring. It offers the ability to capture ultra-high-definition images and videos while submerged for up to three hours, with options for internal storage or live streaming. Chasing Innovation aims to enhance underwater experiences and facilitate effective exploration with its innovative solutions.
ArchForce Technology
Venture Round in 2018
ArchForce Technology, established in 2016, is a Shenzhen-based company that specializes in designing, developing, and providing core business systems and platforms for the securities and financial industry. Its product suite includes a message interconnection platform, a trading platform, a risk control system, and a trading highway, catering to the needs of securities firms, funds, banks, and insurance companies. The company's offerings support transactions, time clearing, risk management, speed markets, investment management, and wealth management marketing, contributing to the advancement of China's financial infrastructure.
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Maijing Gene
Series A in 2018
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
XTX Technology
Series A in 2018
XTX Technology Limited is a semiconductor company based in Shenzhen, China, specializing in high-reliability memory solutions. The company manufactures a variety of flash memory products, including NAND MCP, NOR MCP, SD NAND, and SPI flash, which cater to diverse embedded applications such as mobile devices, automotive equipment, security systems, and home appliances. Additionally, XTX Technology offers System in Package (SIP) assembly services aimed at optimizing customer bill of materials costs and enhancing production efficiency while ensuring software intellectual property security. The company's innovations in semiconductor technology also accommodate various temperature tolerances, supporting a range of applications in consumer electronics, industrial sectors, and medical care.
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the innovation, research, development, manufacture, and sales of new medications. The company aims to establish itself as a leader in the Chinese biopharmaceutical industry, focusing on treatments for cancer, hematologic diseases, and other significant health challenges. Zelgen's business strategy emphasizes addressing unmet medical needs within the domestic market by developing high-quality, safe, effective, and affordable medications. The company's research and development efforts encompass new chemical and biological drugs across various therapeutic areas, including tumors and liver-related diseases.
Huada Empyrean Software
Corporate Round in 2018
Beijing Huada Empyrean Software Co., Ltd. is a leading provider of electronic design automation (EDA) software and services in China, operating as a subsidiary of China Electronics Corporation. Established in June 2009 and headquartered in Wang Jing Hi-Tech Park, Beijing, the company specializes in a wide range of solutions, including analog and mixed analog-digital integrated circuit design, digital system-on-chip design optimization, and flat panel design optimization. With nearly three decades of technological advancement and a robust research and development team, Huada Empyrean Software has positioned itself as the largest EDA software supplier in the country. The company also serves as the relying institution of the National IC CAD Engineering Research Center, fostering collaboration with both domestic and international clients. It has established EDA laboratories at various universities to enhance its cooperative efforts in the industry. The company emphasizes professionalism, dedication, collaboration, and innovation as its core values, aiming for mutual development and success with its partners and customers.
Akeso Biopharma
Series B in 2017
Akeso Biopharma, Inc. is a contract research organization based in Zhongshan, China, specializing in the discovery and development of antibody and protein drugs. Established in 2012, the company offers a range of integrated services to both domestic and international pharmaceutical firms, including protein expression and purification, antibody generation, assay development, humanization, and affinity maturation. Akeso has developed a comprehensive biopharmaceutical research and development platform, focusing on therapeutic areas such as cancer, autoimmune diseases, inflammation, and cardiovascular diseases. With a robust pipeline of over 30 drug candidates, 17 of which are in clinical stages, Akeso is recognized for its innovative approaches, including the development of first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical enterprises to advance the joint development of new drugs, positioning itself as a leader in the biopharmaceutical industry.
AZLOOK
Angel Round in 2017
Azlook is a consumer service platform that offers a unique fashion experience for women, both online and offline. It focuses on connecting high-end fashion accessory brands from Europe and Western countries with fashion-oriented consumers in China. The company not only showcases these premium brands but also provides clothing tailoring services to enhance the overall customer experience. By bridging the gap between international fashion brands and Chinese consumers, Azlook aims to cater to the evolving needs of fashion enthusiasts seeking quality and style.
Dobot is a prominent provider of robotic arm solutions based in China, focusing on making technology accessible and enjoyable. The company specializes in the development of smart desktop robotic arms that enhance manufacturing process efficiency. These robotic arms can be controlled through mobile devices, voice commands, and gestures, offering versatile and responsive solutions tailored for various industries. By integrating full-sensing capabilities, Dobot's products enable users to improve product quality and work efficiency. From its inception with the first desktop robotic arm to the development of STEAM robot kits, Dobot continuously innovates to expand the possibilities of robotic technology.
Youon Bike
Series A in 2017
Youon Technology Co., Ltd. specializes in providing green transportation services through its Internet of Things technology and data platform. The company operates a comprehensive green sharing travel service platform called Wing of the Line, which is available in 220 cities and encompasses 32,000 shared bicycle stations with a fleet of 800,000 bicycles. Youon aims to promote environmentally friendly travel habits and has implemented public bicycle projects across more than 200 counties in China, contributing to the construction of 30,000 public bicycle sites. The Youon national public bicycle system boasts over 15 million active users, with peak rental activity reaching 2.2 million transactions per day. To enhance service delivery, Youon has established 105 branches and operations centers nationwide, employing approximately 4,500 personnel. The company emphasizes technological and service innovation, offering a platform that supports various methods for bike rental, including QR code scanning through popular payment applications.
Makeblock
Series B in 2017
Makeblock, established in 2013 by Jasen Wang and headquartered in Shenzhen, China, specializes in a do-it-yourself robotics construction and programming learning platform. This platform provides mechanical parts, electronic modules, and graphical programming software, empowering STEM learners, educators, and hobbyists to build and customize robots with versatile functionalities like hovercrafts or cars.
Frontier Biotechnologies
Series C in 2017
Frontier Biotechnologies Inc. is a commercial-stage biopharmaceutical company headquartered in Nanjing, China, specializing in the discovery, development, and manufacturing of innovative medicines aimed at improving patient health. Founded in 2013, the company addresses unmet medical needs primarily in anti-HIV treatment and pain management. Its notable products include Aikening, a long-acting HIV fusion inhibitor, and AB001, a transdermal patch designed for musculoskeletal joint pain relief. Additionally, the company is developing a combination regimen of Albuvirtide and 3BNC117, a monoclonal antibody targeting HIV-1 viruses. Frontier Biotech's commitment to excellence spans the entire development cycle, from drug discovery to global clinical trials, with multiple candidates currently in Phase I and Phase II trials in both China and the United States. The company's focus on long-acting therapies and differentiated products positions it as a competitive player in the biopharmaceutical industry.
ASR Microelectronics
Series A in 2017
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.
Wangyudashi
Series A in 2016
Wangyudashi, which operates wangyuhudong.com, is a specialized platform for internet cafe payment and eSports registry developed by Zhejiang Wangjing Network Technology Co., Ltd. The company claims that the platform has already covered 30,000 Internet cafes in China with over ten million users and daily events of over 30.
DataEye is a data solutions provider based in Shenzhen, China, founded in 2013. The company specializes in the mobile gaming industry, offering a digital content marketing platform that includes data analytics, strategy research consulting, and creative advertising services. DataEye's platform enables clients to track and analyze data from game operations and player interactions, facilitating a deeper understanding of consumer preferences. This insight allows clients in the gaming and e-commerce sectors to optimize their product offerings, market strategies, customer support, and brand management, ultimately aiding in brand promotion and sales growth. Through its expert data retrieval technologies and marketing solutions, DataEye supports clients in making informed decisions that enhance their competitive advantage.
Youmi Media is an advertising company founded in 2010 and based in Guangzhou, China. It operates as an intelligent mobile advertising platform, acting as a connector between advertisers and publishers in the mobile app and new-media markets. Youmi offers a range of services, including performance-based advertising, app store optimization, and social media marketing, which are established in both domestic and international markets. The company features several notable products, such as ASOGrow, an automatic app store optimization platform, JadiDuit, which is recognized as Google's first offer wall, and in-house content media solutions. Youmi's mission is to help advertisers engage users effectively while supporting app developers, media buyers, affiliates, and ad networks in maximizing their revenue potential.
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the innovation, research, development, manufacture, and sales of new medications. The company aims to establish itself as a leader in the Chinese biopharmaceutical industry, focusing on treatments for cancer, hematologic diseases, and other significant health challenges. Zelgen's business strategy emphasizes addressing unmet medical needs within the domestic market by developing high-quality, safe, effective, and affordable medications. The company's research and development efforts encompass new chemical and biological drugs across various therapeutic areas, including tumors and liver-related diseases.
Transwarp
Series B in 2016
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.
Guanmai Technology
Series B in 2016
Guanmai Technology is currently the leading SaaS company in the B2B field of fresh food in China. Guanmai, formerly a fresh delivery company for small farmers and girls , has served nearly 30,000 restaurant companies in Guangdong. In 2014-16, it has deeply practiced the B2B business of food distribution, and has accumulated rich experience and industry knowledge of B2B food distribution.
Afanti is an IT company engaged in the production and development of network and gaming products. It also offers a study mobile application that provides real-time answers and assistance to primary and middle school students. Afanti was founded in 2000 and is based in Beijing, China.